Ernest N. A.
- Country
- Spain
- Department
- Medical Oncology
Research Overview
- Dose-Escalation Study of Zongertinib in Patients with Advanced Non-Small Cell Lung Cancer and Solid Tumors with HER2 Aberrations
- Evaluation of Pembrolizumab, Patritumab Deruxtecan, and Drug Combinations in Stage IV Non-Small Cell Lung Cancer: A Phase 2 Umbrella Study
- Phase 3 Randomized Study of Nivolumab and Ipilimumab with Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer
Data & Insights
Has run more than one trial at 512 of 819 partner sites.
Specializations
Hematologic Malignancies
Research activity includes a broad focus on acute myeloid leukemia, myelodysplastic syndromes, multiple myeloma, and aggressive and indolent non-Hodgkin lymphoma subtypes, with additional involvement in chronic lymphocytic leukemia, mantle cell lymphoma, follicular lymphoma, and Waldenström macroglobulinemia.
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Multiple Myeloma
- Diffuse Large B-Cell Lymphoma
- Chronic Lymphocytic Leukemia
The portfolio also spans graft-versus-host disease and other post-transplant complications, reflecting a strong therapeutic interest in cellular therapy and hematologic cancer innovation.
Solid Tumors and Precision Oncology
Clinical research extends across major solid tumor indications, with strong representation in breast cancer, non-small cell lung cancer, urothelial carcinoma, colorectal cancer, gastric cancer, pancreatic cancer, and hepatocellular carcinoma.
- Breast Cancer
- Non-Small Cell Lung Cancer
- Urothelial Carcinoma
- Colorectal Cancer
- Ovarian Cancer
There is notable involvement in biomarker-defined disease areas, including HER2-directed, KRAS G12C-mutated, EGFR-altered, and PIK3CA-mutated cancers, as well as advanced and metastatic disease settings.
Immune-Mediated and Inflammatory Diseases
His research landscape includes immune and inflammatory conditions such as graft-versus-host disease, systemic lupus erythematosus, psoriatic arthritis, atopic dermatitis, dermatomyositis, and vasculitis, alongside selected autoimmune and allergic disorders.
- Systemic Lupus Erythematosus
- Atopic Dermatitis
- Dermatomyositis
- Psoriatic Arthritis
- Chronic Graft-Versus-Host Disease
Additional interests include myasthenia gravis, thyroid eye disease, and uveitis, indicating engagement with therapies targeting immune dysregulation across organ systems.
Cardiovascular and Renal Medicine
Research involvement covers atrial fibrillation, heart failure, acute myocardial infarction, atherosclerotic cardiovascular disease, chronic kidney disease, and kidney transplantation, with attention to both prevention and treatment of high-risk cardiometabolic conditions.
- Atrial Fibrillation
- Heart Failure
- Chronic Kidney Disease
- Kidney Transplantation
- Acute Myocardial Infarction
The portfolio also includes cardiac amyloidosis, transthyretin amyloidosis, hypertriglyceridemia, and stroke prevention, highlighting interest in innovative therapies for vascular and renal risk reduction.
Respiratory, Neurologic, and Rare Diseases
Additional clinical interests include idiopathic pulmonary fibrosis, pulmonary sarcoidosis, chronic obstructive pulmonary disease, bronchiectasis, and respiratory infections, together with neurologic disorders such as amyotrophic lateral sclerosis, multiple sclerosis, and Alzheimer’s disease.
- Idiopathic Pulmonary Fibrosis
- Chronic Obstructive Pulmonary Disease
- Amyotrophic Lateral Sclerosis
- Multiple Sclerosis
- Alzheimer’s Disease
His trial involvement also reaches rare metabolic and genetic disorders such as Niemann-Pick disease type C, Fabry disease, and hereditary transthyretin amyloidosis.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.